UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant [X]

 

Filed by a Party other than the Registrant [  ]

 

Check the appropriate box:

 

[  ] Preliminary Proxy Statement
[  ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[  ] Definitive Proxy Statement
[X] Definitive Additional Materials
[  ] Soliciting Material under §240.14a-12

 

Cocrystal Pharma, Inc.

 

(Name of Registrant as Specified In Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

[X] No fee required.
   
[  ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1) Title of each class of securities to which transaction applies:
     
  (2) Aggregate number of securities to which transaction applies:
     
  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
     
  (4) Proposed maximum aggregate value of transaction:
     
  (5) Total fee paid:
     

 

[  ] Fee paid previously with preliminary materials.
   
[  ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

  (1) Amount Previously Paid:
     
  (2) Form, Schedule or Registration Statement No.:
     
  (3) Filing Party:
     
  (4) Date Filed:
     

 

 

 

   

 

 

***  Exercise Your Right to Vote  ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 09, 2020.

 
                 
                 
  COCRYSTAL PHARMA, INC.  

Meeting Information

    Meeting Type:    Annual Meeting
        For holders as of:    April 20, 2020
        Date:  June 09, 2020 Time: 2:00 p.m. EST
 

COCRYSTAL PHARMA, INC.

19805 North Creek Parkway

Bothell, WA 98011

    Location:  

Meeting live via the Internet– please visit
www.virtualshareholdermeeting.com/COCP2020

     

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

         
      We encourage you to access and review all of the important information contained in the proxy materials before voting.
       
      See the reverse side of this notice to obtain proxy materials and voting instructions.

    

     
                   
 
 
 
             
   

Before You Vote

How to Access the Proxy Materials 

     

Proxy Materials Available to VIEW or RECEIVE:

1. Notice & Proxy Statement 2. Annual Report on Form 10-K

      How to View Online: 
      Have the information that is printed in the box marked by the arrow à (located on the following page) and visit: www.proxyvote.com.
     

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

      1) BY INTERNET: www.proxyvote.com  
      2) BY TELEPHONE: 1-800-579-1639  
      3) BY E-MAIL*: Sendmaterial@proxyvote.com  
      *If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow à   (located on the following page) in the subject line.
      Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 26, 2020 to facilitate timely delivery.
   

How To Vote

Please Choose One of the Following Voting Methods

   

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet:  To vote now by the Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow à available and follow the instructions.

  Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
           

                   
VOTING ITEMS              
                   
The Board of Directors recommends you vote FOR all listed nominees      
                 
1.

Elect five members to our Board of Directors for a one-year term expiring at the next annual meeting of shareholders.

 

Nominees:

 

01) Gary Wilcox     02) Phillip Frost     03) Roger Kornberg     04) Steve Rubin     05) Anthony Japour

 

The Board of Directors recommends you vote FOR proposal 2: 

 

   
 2.

Ratify the appointment of Weinberg & Company, P.A., as our independent registered public accounting firm for the fiscal year ending December 31, 2020.

 

NOTE: Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.